Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Stocks

Compare stocks in the Canadian market. Find the best stocks in Canada by average analyst price target and latest recommendations

Compare up to 40 stocks

Comparison Results

NameSectorPriceVolumeMarket CapP/E RatioDividend YieldAnalyst ConsensusAnalyst Price TargetSmart ScoreLeveraged ETFArticleFollow
CHNXFCHNXFHealthcare$0.010.00$291.20K-0.23――

Top 10 Popular Investment Themes

View all Stock categories

Performance Comparison

Performance comparison by ticker
TickerCompany NamePriceChange% Change
CHNXFChitogenX0.010.000.00%
-0.01%-0.01%-0.01%-0%0%0%Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26

Custom Stock Latest News

Compare up to 40 stocks

  • ChitogenX Reports Financial Growth in Q2 2025
    ChitogenX Reports Financial Growth in Q2 2025

    ChitogenX (TSE:CHGX) has released an update. ChitogenX Inc., a clinical-stage regenerative medicine company, has reported a decrease in net loss and a significant reduction in research and development (R&D) as

    2y ago
  • ChitogenX Shareholders Confirm Directors and Auditor
    ChitogenX Shareholders Confirm Directors and Auditor

    ChitogenX (TSE:CHGX) has released an update. ChitogenX Inc., a pioneering firm in regenerative medicine, has concluded its virtual Annual General Meeting, successfully re-electing six director nominees and appointing Audacie Inc.

    2y ago
  • ChitogenX Advances Towards Commercial Readiness
    ChitogenX Advances Towards Commercial Readiness

    ChitogenX (TSE:CHGX) has released an update. ChitogenX, a clinical-stage regenerative medicine company, has reported a marginal Q1 2025 loss of $0.2 million, a notable improvement from the previous year, alongside

    2y ago
  • ChitogenX Advances Regenerative Medicine and Finances
    ChitogenX Advances Regenerative Medicine and Finances

    ChitogenX (TSE:CHGX) has released an update. ChitogenX Inc., a clinical-stage regenerative medicine company, has reported significant strides in its fiscal year 2024, including the advancement of a new skin repair

    2y ago
  • ChitogenX Inc. CEO Steps Down, Interim Named
    ChitogenX Inc. CEO Steps Down, Interim Named

    Chitogenx Inc. (TSE:CHGX) has released an update. ChitogenX Inc., a company specializing in regenerative medicine, has announced the departure of their CEO, Philippe Deschamps, and his resignation from the Board

    2y ago

Compare Stocks Side-by-Side

Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.

Key Features of Our Stock Comparison

  • Comprehensive Analysis: Compare up to 40 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
  • Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
  • Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
  • Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
  • Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.

How to Use the Stock Comparison Tool

Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.

Popular Stock Comparisons

Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).

Why Compare Stocks?

Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.

Custom Stock - FAQ

Which Custom stocks have a "Strong Buy" analyst rating?
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Custom stocks overpriced?
ChitogenX's stock price is currently $0.01, and its average 12-month price target is N/A.
Which Custom stocks pay dividends?
ChitogenX does not currently pay dividends.